AI tool aims to personalize stomach cancer care
NCT ID NCT07401199
Summary
This study aims to develop an artificial intelligence (AI) system to predict how well a patient's stomach cancer will respond to standard drug treatment before surgery. Researchers will collect data from 2,000 patients receiving standard chemo-immunotherapy to train the AI using their CT scans and tissue samples. If successful, this tool could help doctors in the future choose the most effective treatment for each patient and avoid unnecessary side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER (GC) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.